Arbutus Biopharma Appoints Tram Tran, M.D. to its Board of Directors

NEXT STORY
NRx Pharmaceuticals Receives US Food and Drug Administration Review of ZYESAMI® (aviptadil) Manufacturing Information
PREV STORY
Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Worldwide Active Pharmaceutical Ingredient Industry to 2027 – by Product Type, Form, Manufacturer Type, Application and Region

author_avatar
NASDAQ Market News

InflaRx Announces Positive Topline Results for Vilobelimab from the U.S. Phase II ANCA-Associated Vasculitis IXPLORE Study

author_avatar
NASDAQ Market News

NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia

NIH study found 58% of patients with treatment-naïve severe aplastic anemia (SAA) achieved a ...

author_avatar
NASDAQ Market News